NIH #5U24CA248455-05
Advanced development of the Cancer Dependency Map portal (DepMap.org)
- Amount
- $735K
- Period
- 2020-09-03 → 2025-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at BROAD INSTITUTE, INC.
Cancer Genomics and Diagnostics · Cancer Research
5 total · 0 active
NIH #5U24CA248455-05
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA248455-04
Awarded at BROAD INSTITUTE, INC.
NIH #5U24CA248455-03
Awarded at BROAD INSTITUTE, INC.
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Nature reviews. Cancer · 2026-04-23
Figshare · 2026-03-27 · 1 citations
Figshare · 2026-03-27
bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-05
Cancer Research · 2026-01-20
2025-12-11
Figure S6 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
2025-10-23
Figure S4 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
Cover Art from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
Figure S5 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
Figure S3 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
Figure S1 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
Figure S7 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23
Figure S2 from Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
2025-10-23